PDL BIOPHARMA, INC.
PDL BIOPHARMA, INC. (PDLI) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 708 transactions totaling $56.1M, demonstrating a bullish sentiment with $9.2M in net insider flow. The most recent transaction on Feb 1, 2021 involved a purchase of 187,061 shares valued at $383.5K.
PDLI Insider Activity Summary
Who Is Buying PDLI Stock?
No significant insider buying has been recorded for PDLI in the recent period.
Who Is Selling PDLI Stock?
No significant insider selling has been recorded for PDLI in the recent period.
Is PDL BIOPHARMA, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PDLI is bullish with an Insider Alignment Score of 58/100 and a net flow of $9.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PDLI Frequently Asked Questions
Understanding PDLI Insider Activity
Insider trading at PDL BIOPHARMA, INC. (PDLI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading PDLI stock, having executed 708 transactions in the past 90 days. The most active insider is Point Capital L.p. Silver (Executive), who has made 5 transactions totaling $20.3M.
Related Tools
Track PDL BIOPHARMA, INC. Insider Activity
Get notified when executives and directors at PDLI file new Form 4 transactions